Fairchem Organics Ltd Q2 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/lbimudocvnnlmsubtijpqnay.pdf

Key Takeaways


Isosteric Acid: The New Growth Vector

Nahoosh Jariwala: "USA and European specialty companies were pleasantly surprised by the fact that an Indian company is venturing in the global market of isosteric acid, which hitherto has been the domain of European and U.S. companies only."

Margin Recovery: Drivers and Trajectory

Nahoosh Jariwala: "to be frank, our internal goal always has been to remain in 14% to 16% EBITDA range. We strive to reach there only, but many times the external factors are such that they are beyond our control, and we cannot do anything about it."

Demand and Volume Dynamics


China Dumping: A One-Quarter Distortion


Raw Material and Competitive Position

Nahoosh Jariwala: "There is nobody in India."

Guidance & Commitments

CommitmentSpecificsTimeline
Isosteric acid commercial shipmentsBegin supplies immediately upon approval; stability tests of 90-120 days underwayJanuary-March quarter (optimistic)
Q3 EBITDA marginReach about 12-13%Q3 FY24 (October-December)
Subsequent margin targetReach 15% EBITDA marginAfter Q3, if conditions remain stable
Full margin recoveryReturn to 15-16% EBITDA range, driven by isosteric acid ramp and higher utilizationApril-June quarter onwards
EBITDA aspirationAchieve roughly ₹150 crores of EBITDA; all investments done, product development overTwo years down the line (aspiration, not firm guidance)
Volume growthCertain to achieve growth in quantity processed and soldOngoing

Key Metrics

MetricQ2 FY24
Revenue from operations₹148 cr
EBITDA₹18 cr
EBITDA margin12.16%
Net profit₹10 cr
PAT margin6.77%
H1 FY24 revenue from operations₹313 cr
H1 FY24 EBITDA₹29 cr, EBITDA margin 9.11%
H1 FY24 net profit₹16 cr, PAT margin 5.24%
Finished goods sales volume change~8% decline QoQ
Finished goods sales value change~5% decline QoQ
Quantity processed change~9% increase QoQ
Capacity utilization~65%
Revenue mix: Paint, printing & adhesive₹117.30 cr
Revenue mix: Nutraceutical₹8.4 cr
Revenue mix: Soap, fuel, etc.₹22.9 cr
Isosteric acid peak capacity revenue potential₹100–125 cr per annum
Isosteric acid stability test approval timeline90 to 120 days